ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Safety Lancets Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-26S355
Home | Market Reports | Health| Medical Devices & Equipment
Global Safety Lancets Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Safety Lancets Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-26S355
Report
July 2025
Pages:169
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
B. Braun
Terumo
Nipro
Sarstedt
Greiner Bio One
Roche
Ascensia
LifeScan Inc
Cardinal Health
Arkray
ICU Medical
Owen Mumford
Hemocue AB
HTL-Strefa
Ultimed
Tianjin Huahong
Guangzhou iCare Medical
Shandong Lianfa
SteriLance Medical

Safety Lancets Market Size

In 2024, the global market size of Safety Lancets was estimated to be worth US$ 650 million and is forecast to reach approximately US$ 947 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.

Safety Lancets Market

Safety Lancets Market

Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
Drivers of the Safety Lancets Market:
Increasing Prevalence of Diabetes: The growing incidence of diabetes globally has led to a rise in the demand for frequent blood glucose monitoring. Safety lancets are widely used in diabetes management, driving the market.
Focus on Safety and Infection Control: Concerns over needle-stick injuries and blood borne infections are pushing healthcare providers to adopt safer devices like safety lancets, which minimize these risks through single-use mechanisms.
Rising Home Healthcare Adoption: The trend toward home-based care, especially for patients with chronic conditions, has increased the demand for user-friendly medical devices, including safety lancets.
Technological Innovation: Advancements in lancet design, such as automatic, pain-minimizing, and ergonomically improved lancets, are enhancing patient experience and encouraging wider adoption.
Government Regulations and Support: Many governments have implemented strict regulations that favor the use of safety-engineered devices to improve healthcare worker safety, fostering the growth of the safety lancets market.
Challenges of the Safety Lancets Market:
Higher Costs: Safety lancets tend to be more expensive than traditional lancets, which can limit adoption, especially in low-resource healthcare settings.
Lack of Awareness in Developing Regions: Limited awareness of safety lancets, along with insufficient healthcare infrastructure in developing countries, hampers market penetration.
Environmental Impact: The single-use nature of safety lancets contributes to medical waste, raising concerns about environmental sustainability and prompting the search for more eco-friendly solutions.
Competition from Alternative Technologies: Emerging blood sampling technologies, such as continuous glucose monitoring (CGM) systems that reduce the need for finger pricking, may present competition to safety lancets.
Limited Reimbursement Policies: In some regions, the lack of favorable reimbursement policies for diagnostic devices like safety lancets can act as a barrier to widespread adoption.
Global key players of safety lancets include HTL-STREFA, BD, Roche, etc. The top three players hold a share about 33%. Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Safety Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Lancets.
The Safety Lancets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Safety Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Safety Lancets Market Report

Report Metric Details
Report Name Safety Lancets Market
Forecasted market size in 2031 approximately US$ 947 million
CAGR 5.6%
Forecasted years 2025 - 2031
Segment by Type
  • Safety Lancets with Needle
  • Safety Lancets with Blade
Segment by Application
  • Hospital & Clinics
  • Home
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health, ARKRAY, ICU Medical, Owen Mumford, HemoCue, Greiner Bio One, HTL-STREFA, Sarstedt, UltiMed, Tianjin Huahong, Guangzhou iCare Medical, Shandong Lianfa, SteriLance Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Safety Lancets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Safety Lancets sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Safety Lancets Market size in 2031?

Ans: The Safety Lancets Market size in 2031 will be approximately US$ 947 million.

What is the market share of major companies in Safety Lancets Market?

Ans: The top three players hold a share about 33%.

What is the Safety Lancets Market share by region?

Ans: Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.

Who are the main players in the Safety Lancets Market report?

Ans: The main players in the Safety Lancets Market are Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health, ARKRAY, ICU Medical, Owen Mumford, HemoCue, Greiner Bio One, HTL-STREFA, Sarstedt, UltiMed, Tianjin Huahong, Guangzhou iCare Medical, Shandong Lianfa, SteriLance Medical

What are the Application segmentation covered in the Safety Lancets Market report?

Ans: The Applications covered in the Safety Lancets Market report are Hospital & Clinics, Home, Other

What are the Type segmentation covered in the Safety Lancets Market report?

Ans: The Types covered in the Safety Lancets Market report are Safety Lancets with Needle, Safety Lancets with Blade

1 Study Coverage
1.1 Safety Lancets Product Introduction
1.2 Market by Type
1.2.1 Global Safety Lancets Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Market by Application
1.3.1 Global Safety Lancets Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital & Clinics
1.3.3 Home
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Safety Lancets Market Size Estimates and Forecasts
2.1.1 Global Safety Lancets Revenue 2020-2031
2.1.2 Global Safety Lancets Sales 2020-2031
2.2 Safety Lancets Market Size by Region: 2024 Versus 2031
2.3 Safety Lancets Sales by Region (2020-2031)
2.3.1 Global Safety Lancets Sales by Region: 2020-2025
2.3.2 Global Safety Lancets Sales Forecast by Region (2026-2031)
2.3.3 Global Safety Lancets Sales Market Share by Region (2020-2031)
2.4 Safety Lancets Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Safety Lancets Revenue by Region: 2020-2025
2.4.2 Global Safety Lancets Revenue Forecast by Region (2026-2031)
2.4.3 Global Safety Lancets Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Safety Lancets Sales by Type (2020-2031)
3.1.1.1 Global Safety Lancets Sales Volume by Type (2020-2031)
3.1.1.2 Global Safety Lancets Sales Market Share by Type (2020-2031)
3.1.2 Global Safety Lancets Revenue by Type (2020-2031)
3.1.2.1 Global Safety Lancets Revenue by Type (2020-2031)
3.1.2.2 Global Safety Lancets Revenue Market Share by Type (2020-2031)
3.1.3 Safety Lancets Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Safety Lancets Sales by Application (2020-2031)
3.2.1.1 Global Safety Lancets Sales Volume by Application (2020-2031)
3.2.1.2 Global Safety Lancets Sales Market Share by Application (2020-2031)
3.2.2 Global Safety Lancets Revenue by Application (2020-2031)
3.2.2.1 Global Safety Lancets Revenue by Application (2020-2031)
3.2.2.2 Global Safety Lancets Revenue Market Share by Application (2020-2031)
3.2.3 Safety Lancets Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Safety Lancets with Needle of Safety Lancets Revenue Market Share by Application
3.3.2 Safety Lancets with Blade of Safety Lancets Revenue Market Share by Application
4 Global Safety Lancets by Manufacturers
4.1 Global Top Safety Lancets Manufacturers by Sales (2020-2025)
4.1.1 Global Safety Lancets Sales by Manufacturer (2020-2025)
4.1.2 Global Safety Lancets Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Safety Lancets Manufacturers by Revenue (2020-2025)
4.2.1 Global Safety Lancets Revenue by Manufacturer (2020-2025)
4.2.2 Global Safety Lancets Revenue Share by Manufacturer (2020-2025)
4.3 Global Safety Lancets Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Safety Lancets Manufacturers Covered: Ranking by Revenue
4.4.2 Global Safety Lancets Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Safety Lancets Manufacturing Base Distribution, Product Type
4.5.1 Safety Lancets Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Safety Lancets Market
4.5.3 Manufacturers Safety Lancets Product Type and Application
4.5.4 Safety Lancets with Needle Market Sales of Safety Lancets by Manufacturer
4.5.5 Safety Lancets with Blade Market Sales of Safety Lancets by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Company Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Safety Lancets Products Offered
5.1.4 Roche Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Roche Safety Lancets Sales by Product in 2024
5.1.6 Roche Safety Lancets Sales by Application in 2024
5.1.7 Roche Safety Lancets Sales by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 BD
5.2.1 BD Company Information
5.2.2 BD Description, Business Overview
5.2.3 BD Safety Lancets Products Offered
5.2.4 BD Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.2.5 BD Safety Lancets Sales by Product in 2024
5.2.6 BD Safety Lancets Sales by Application in 2024
5.2.7 BD Safety Lancets Sales by Geographic Area in 2024
5.2.8 BD Recent Developments
5.3 Ascensia
5.3.1 Ascensia Company Information
5.3.2 Ascensia Description, Business Overview
5.3.3 Ascensia Safety Lancets Products Offered
5.3.4 Ascensia Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Ascensia Safety Lancets Sales by Product in 2024
5.3.6 Ascensia Safety Lancets Sales by Application in 2024
5.3.7 Ascensia Safety Lancets Sales by Geographic Area in 2024
5.3.8 Ascensia Recent Developments
5.4 Lifescan
5.4.1 Lifescan Company Information
5.4.2 Lifescan Description, Business Overview
5.4.3 Lifescan Safety Lancets Products Offered
5.4.4 Lifescan Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Lifescan Safety Lancets Sales by Product in 2024
5.4.6 Lifescan Safety Lancets Sales by Application in 2024
5.4.7 Lifescan Safety Lancets Sales by Geographic Area in 2024
5.4.8 Lifescan Recent Developments
5.5 B. Braun
5.5.1 B. Braun Company Information
5.5.2 B. Braun Description, Business Overview
5.5.3 B. Braun Safety Lancets Products Offered
5.5.4 B. Braun Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.5.5 B. Braun Safety Lancets Sales by Product in 2024
5.5.6 B. Braun Safety Lancets Sales by Application in 2024
5.5.7 B. Braun Safety Lancets Sales by Geographic Area in 2024
5.5.8 B. Braun Recent Developments
5.6 Terumo
5.6.1 Terumo Company Information
5.6.2 Terumo Description, Business Overview
5.6.3 Terumo Safety Lancets Products Offered
5.6.4 Terumo Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Terumo Safety Lancets Sales by Product in 2024
5.6.6 Terumo Safety Lancets Sales by Application in 2024
5.6.7 Terumo Safety Lancets Sales by Geographic Area in 2024
5.6.8 Terumo Recent Developments
5.7 Nipro
5.7.1 Nipro Company Information
5.7.2 Nipro Description, Business Overview
5.7.3 Nipro Safety Lancets Products Offered
5.7.4 Nipro Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Nipro Safety Lancets Sales by Product in 2024
5.7.6 Nipro Safety Lancets Sales by Application in 2024
5.7.7 Nipro Safety Lancets Sales by Geographic Area in 2024
5.7.8 Nipro Recent Developments
5.8 Cardinal Health
5.8.1 Cardinal Health Company Information
5.8.2 Cardinal Health Description, Business Overview
5.8.3 Cardinal Health Safety Lancets Products Offered
5.8.4 Cardinal Health Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Cardinal Health Safety Lancets Sales by Product in 2024
5.8.6 Cardinal Health Safety Lancets Sales by Application in 2024
5.8.7 Cardinal Health Safety Lancets Sales by Geographic Area in 2024
5.8.8 Cardinal Health Recent Developments
5.9 ARKRAY
5.9.1 ARKRAY Company Information
5.9.2 ARKRAY Description, Business Overview
5.9.3 ARKRAY Safety Lancets Products Offered
5.9.4 ARKRAY Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.9.5 ARKRAY Safety Lancets Sales by Product in 2024
5.9.6 ARKRAY Safety Lancets Sales by Application in 2024
5.9.7 ARKRAY Safety Lancets Sales by Geographic Area in 2024
5.9.8 ARKRAY Recent Developments
5.10 ICU Medical
5.10.1 ICU Medical Company Information
5.10.2 ICU Medical Description, Business Overview
5.10.3 ICU Medical Safety Lancets Products Offered
5.10.4 ICU Medical Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.10.5 ICU Medical Safety Lancets Sales by Product in 2024
5.10.6 ICU Medical Safety Lancets Sales by Application in 2024
5.10.7 ICU Medical Safety Lancets Sales by Geographic Area in 2024
5.10.8 ICU Medical Recent Developments
5.11 Owen Mumford
5.11.1 Owen Mumford Company Information
5.11.2 Owen Mumford Description, Business Overview
5.11.3 Owen Mumford Safety Lancets Products Offered
5.11.4 Owen Mumford Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Owen Mumford Safety Lancets Sales by Product in 2024
5.11.6 Owen Mumford Safety Lancets Sales by Application in 2024
5.11.7 Owen Mumford Safety Lancets Sales by Geographic Area in 2024
5.11.8 Owen Mumford Recent Developments
5.12 HemoCue
5.12.1 HemoCue Company Information
5.12.2 HemoCue Description, Business Overview
5.12.3 HemoCue Safety Lancets Products Offered
5.12.4 HemoCue Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.12.5 HemoCue Safety Lancets Sales by Product in 2024
5.12.6 HemoCue Safety Lancets Sales by Application in 2024
5.12.7 HemoCue Safety Lancets Sales by Geographic Area in 2024
5.12.8 HemoCue Recent Developments
5.13 Greiner Bio One
5.13.1 Greiner Bio One Company Information
5.13.2 Greiner Bio One Description, Business Overview
5.13.3 Greiner Bio One Safety Lancets Products Offered
5.13.4 Greiner Bio One Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Greiner Bio One Safety Lancets Sales by Product in 2024
5.13.6 Greiner Bio One Safety Lancets Sales by Application in 2024
5.13.7 Greiner Bio One Safety Lancets Sales by Geographic Area in 2024
5.13.8 Greiner Bio One Recent Developments
5.14 HTL-STREFA
5.14.1 HTL-STREFA Company Information
5.14.2 HTL-STREFA Description, Business Overview
5.14.3 HTL-STREFA Safety Lancets Products Offered
5.14.4 HTL-STREFA Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.14.5 HTL-STREFA Safety Lancets Sales by Product in 2024
5.14.6 HTL-STREFA Safety Lancets Sales by Application in 2024
5.14.7 HTL-STREFA Safety Lancets Sales by Geographic Area in 2024
5.14.8 HTL-STREFA Recent Developments
5.15 Sarstedt
5.15.1 Sarstedt Company Information
5.15.2 Sarstedt Description, Business Overview
5.15.3 Sarstedt Safety Lancets Products Offered
5.15.4 Sarstedt Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Sarstedt Safety Lancets Sales by Product in 2024
5.15.6 Sarstedt Safety Lancets Sales by Application in 2024
5.15.7 Sarstedt Safety Lancets Sales by Geographic Area in 2024
5.15.8 Sarstedt Recent Developments
5.16 UltiMed
5.16.1 UltiMed Company Information
5.16.2 UltiMed Description, Business Overview
5.16.3 UltiMed Safety Lancets Products Offered
5.16.4 UltiMed Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.16.5 UltiMed Safety Lancets Sales by Product in 2024
5.16.6 UltiMed Safety Lancets Sales by Application in 2024
5.16.7 UltiMed Safety Lancets Sales by Geographic Area in 2024
5.16.8 UltiMed Recent Developments
5.17 Tianjin Huahong
5.17.1 Tianjin Huahong Company Information
5.17.2 Tianjin Huahong Description, Business Overview
5.17.3 Tianjin Huahong Safety Lancets Products Offered
5.17.4 Tianjin Huahong Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Tianjin Huahong Safety Lancets Sales by Product in 2024
5.17.6 Tianjin Huahong Safety Lancets Sales by Application in 2024
5.17.7 Tianjin Huahong Safety Lancets Sales by Geographic Area in 2024
5.17.8 Tianjin Huahong Recent Developments
5.18 Guangzhou iCare Medical
5.18.1 Guangzhou iCare Medical Company Information
5.18.2 Guangzhou iCare Medical Description, Business Overview
5.18.3 Guangzhou iCare Medical Safety Lancets Products Offered
5.18.4 Guangzhou iCare Medical Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Guangzhou iCare Medical Safety Lancets Sales by Product in 2024
5.18.6 Guangzhou iCare Medical Safety Lancets Sales by Application in 2024
5.18.7 Guangzhou iCare Medical Safety Lancets Sales by Geographic Area in 2024
5.18.8 Guangzhou iCare Medical Recent Developments
5.19 Shandong Lianfa
5.19.1 Shandong Lianfa Company Information
5.19.2 Shandong Lianfa Description, Business Overview
5.19.3 Shandong Lianfa Safety Lancets Products Offered
5.19.4 Shandong Lianfa Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Shandong Lianfa Safety Lancets Sales by Product in 2024
5.19.6 Shandong Lianfa Safety Lancets Sales by Application in 2024
5.19.7 Shandong Lianfa Safety Lancets Sales by Geographic Area in 2024
5.19.8 Shandong Lianfa Recent Developments
5.20 SteriLance Medical
5.20.1 SteriLance Medical Company Information
5.20.2 SteriLance Medical Description, Business Overview
5.20.3 SteriLance Medical Safety Lancets Products Offered
5.20.4 SteriLance Medical Safety Lancets Sales, Revenue and Gross Margin (2020-2025)
5.20.5 SteriLance Medical Safety Lancets Sales by Product in 2024
5.20.6 SteriLance Medical Safety Lancets Sales by Application in 2024
5.20.7 SteriLance Medical Safety Lancets Sales by Geographic Area in 2024
5.20.8 SteriLance Medical Recent Developments
6 North America
6.1 North America Safety Lancets Market Size YoY Growth 2020-2031
6.2 North America Safety Lancets Market Facts & Figures by Country
6.2.1 North America Safety Lancets Sales by Country (2020-2031)
6.2.2 North America Safety Lancets Revenue by Country (2020-2031)
6.3 North America Safety Lancets Sales by Type (2020-2025)
6.4 North America Safety Lancets Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Safety Lancets Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Safety Lancets Market Facts & Figures by Region
7.2.1 Asia-Pacific Safety Lancets Sales by Region (2020-2031)
7.2.2 Asia-Pacific Safety Lancets Revenue by Region (2020-2031)
7.3 Asia-Pacific Safety Lancets Sales by Type (2020-2025)
7.4 Asia-Pacific Safety Lancets Sales by Application (2020-2025)
8 Europe
8.1 Europe Safety Lancets Market Size YoY Growth 2020-2031
8.2 Europe Safety Lancets Market Facts & Figures by Country
8.2.1 Europe Safety Lancets Sales by Country (2020-2031)
8.2.2 Europe Safety Lancets Revenue by Country (2020-2031)
8.3 Europe Safety Lancets Sales by Type (2020-2025)
8.4 Europe Safety Lancets Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Safety Lancets Market Size YoY Growth 2020-2031
9.2 Latin America Safety Lancets Market Facts & Figures by Country
9.2.1 Latin America Safety Lancets Sales by Country (2020-2031)
9.2.2 Latin America Safety Lancets Revenue by Country (2020-2031)
9.3 Latin America Safety Lancets Sales by Type (2020-2025)
9.4 Latin America Safety Lancets Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Safety Lancets Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Safety Lancets Market Facts & Figures by Country
10.2.1 Middle East and Africa Safety Lancets Sales by Country (2020-2031)
10.2.2 Middle East and Africa Safety Lancets Revenue by Country (2020-2031)
10.3 Middle East and Africa Safety Lancets Sales by Type (2020-2025)
10.4 Middle East and Africa Safety Lancets Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Safety Lancets Supply Chain Analysis
11.2 Safety Lancets Key Raw Materials and Upstream Suppliers
11.3 Safety Lancets Clients Analysis
11.4 Safety Lancets Sales Channel and Sales Model Analysis
11.4.1 Safety Lancets Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Safety Lancets Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Safety Lancets Distributors
12 Safety Lancets Market Dynamics
12.1 Safety Lancets Industry Trends
12.2 Safety Lancets Market Drivers
12.3 Safety Lancets Market Challenges
12.4 Safety Lancets Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
BD
B. Braun
Terumo
Nipro
Sarstedt
Greiner Bio One
Roche
Ascensia
LifeScan Inc
Cardinal Health
Arkray
ICU Medical
Owen Mumford
Hemocue AB
HTL-Strefa
Ultimed
Tianjin Huahong
Guangzhou iCare Medical
Shandong Lianfa
SteriLance Medical
List of Tables
 Table 1. Global Safety Lancets Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Safety Lancets Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Safety Lancets Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Safety Lancets Sales by Region (2020-2025) & (M Units)
 Table 5. Global Safety Lancets Sales Forecast by Region (2026-2031) & (M Units)
 Table 6. Global Safety Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Safety Lancets Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Safety Lancets Sales Volume by Type (2020-2025) & (M Units)
 Table 9. Global Safety Lancets Sales Volume by Type (2026-2031) & (M Units)
 Table 10. Global Safety Lancets Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Safety Lancets Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Safety Lancets Sales Volume by Application (2020-2025) & (M Units)
 Table 13. Global Safety Lancets Sales Volume by Application (2026-2031) & (M Units)
 Table 14. Global Safety Lancets Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Safety Lancets Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Safety Lancets Sales by Manufacturer (2020-2025) & (M Units)
 Table 17. Global Safety Lancets Sales Share by Manufacturer (2020-2025)
 Table 18. Safety Lancets Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Safety Lancets Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Safety Lancets Price (2020-2025) & (US$/K Units)
 Table 21. Ranking of Global Top Safety Lancets Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Safety Lancets Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Safety Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Lancets as of 2024)
 Table 24. Safety Lancets Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Safety Lancets Market
 Table 26. Manufacturers Safety Lancets Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Roche Company Information
 Table 29. Roche Description and Business Overview
 Table 30. Roche Safety Lancets Product
 Table 31. Roche Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 32. Roche Sales Proportion of Safety Lancets by Product in 2024
 Table 33. Roche Sales Proportion of Safety Lancets by Application in 2024
 Table 34. Roche Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 35. Roche Recent Developments
 Table 36. BD Company Information
 Table 37. BD Description and Business Overview
 Table 38. BD Safety Lancets Product
 Table 39. BD Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 40. BD Sales Proportion of Safety Lancets by Product in 2024
 Table 41. BD Sales Proportion of Safety Lancets by Application in 2024
 Table 42. BD Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 43. BD Recent Developments
 Table 44. Ascensia Company Information
 Table 45. Ascensia Description and Business Overview
 Table 46. Ascensia Safety Lancets Product
 Table 47. Ascensia Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 48. Ascensia Sales Proportion of Safety Lancets by Product in 2024
 Table 49. Ascensia Sales Proportion of Safety Lancets by Application in 2024
 Table 50. Ascensia Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 51. Ascensia Recent Developments
 Table 52. Lifescan Company Information
 Table 53. Lifescan Description and Business Overview
 Table 54. Lifescan Safety Lancets Product
 Table 55. Lifescan Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 56. Lifescan Sales Proportion of Safety Lancets by Product in 2024
 Table 57. Lifescan Sales Proportion of Safety Lancets by Application in 2024
 Table 58. Lifescan Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 59. Lifescan Recent Developments
 Table 60. B. Braun Company Information
 Table 61. B. Braun Description and Business Overview
 Table 62. B. Braun Safety Lancets Product
 Table 63. B. Braun Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 64. B. Braun Sales Proportion of Safety Lancets by Product in 2024
 Table 65. B. Braun Sales Proportion of Safety Lancets by Application in 2024
 Table 66. B. Braun Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 67. B. Braun Recent Developments
 Table 68. Terumo Company Information
 Table 69. Terumo Description and Business Overview
 Table 70. Terumo Safety Lancets Product
 Table 71. Terumo Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 72. Terumo Sales Proportion of Safety Lancets by Product in 2024
 Table 73. Terumo Sales Proportion of Safety Lancets by Application in 2024
 Table 74. Terumo Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 75. Terumo Recent Developments
 Table 76. Nipro Company Information
 Table 77. Nipro Description and Business Overview
 Table 78. Nipro Safety Lancets Product
 Table 79. Nipro Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 80. Nipro Sales Proportion of Safety Lancets by Product in 2024
 Table 81. Nipro Sales Proportion of Safety Lancets by Application in 2024
 Table 82. Nipro Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 83. Nipro Recent Developments
 Table 84. Cardinal Health Company Information
 Table 85. Cardinal Health Description and Business Overview
 Table 86. Cardinal Health Safety Lancets Product
 Table 87. Cardinal Health Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 88. Cardinal Health Sales Proportion of Safety Lancets by Product in 2024
 Table 89. Cardinal Health Sales Proportion of Safety Lancets by Application in 2024
 Table 90. Cardinal Health Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 91. Cardinal Health Recent Developments
 Table 92. ARKRAY Company Information
 Table 93. ARKRAY Description and Business Overview
 Table 94. ARKRAY Safety Lancets Product
 Table 95. ARKRAY Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 96. ARKRAY Sales Proportion of Safety Lancets by Product in 2024
 Table 97. ARKRAY Sales Proportion of Safety Lancets by Application in 2024
 Table 98. ARKRAY Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 99. ARKRAY Recent Developments
 Table 100. ICU Medical Company Information
 Table 101. ICU Medical Description and Business Overview
 Table 102. ICU Medical Safety Lancets Product
 Table 103. ICU Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 104. ICU Medical Sales Proportion of Safety Lancets by Product in 2024
 Table 105. ICU Medical Sales Proportion of Safety Lancets by Application in 2024
 Table 106. ICU Medical Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 107. ICU Medical Recent Developments
 Table 108. Owen Mumford Company Information
 Table 109. Owen Mumford Description and Business Overview
 Table 110. Owen Mumford Safety Lancets Product
 Table 111. Owen Mumford Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 112. Owen Mumford Sales Proportion of Safety Lancets by Product in 2024
 Table 113. Owen Mumford Sales Proportion of Safety Lancets by Application in 2024
 Table 114. Owen Mumford Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 115. Owen Mumford Recent Developments
 Table 116. HemoCue Company Information
 Table 117. HemoCue Description and Business Overview
 Table 118. HemoCue Safety Lancets Product
 Table 119. HemoCue Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 120. HemoCue Sales Proportion of Safety Lancets by Product in 2024
 Table 121. HemoCue Sales Proportion of Safety Lancets by Application in 2024
 Table 122. HemoCue Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 123. HemoCue Recent Developments
 Table 124. Greiner Bio One Company Information
 Table 125. Greiner Bio One Description and Business Overview
 Table 126. Greiner Bio One Safety Lancets Product
 Table 127. Greiner Bio One Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 128. Greiner Bio One Sales Proportion of Safety Lancets by Product in 2024
 Table 129. Greiner Bio One Sales Proportion of Safety Lancets by Application in 2024
 Table 130. Greiner Bio One Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 131. Greiner Bio One Recent Developments
 Table 132. HTL-STREFA Company Information
 Table 133. HTL-STREFA Description and Business Overview
 Table 134. HTL-STREFA Safety Lancets Product
 Table 135. HTL-STREFA Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 136. HTL-STREFA Sales Proportion of Safety Lancets by Product in 2024
 Table 137. HTL-STREFA Sales Proportion of Safety Lancets by Application in 2024
 Table 138. HTL-STREFA Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 139. HTL-STREFA Recent Developments
 Table 140. Sarstedt Company Information
 Table 141. Sarstedt Description and Business Overview
 Table 142. Sarstedt Safety Lancets Product
 Table 143. Sarstedt Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 144. Sarstedt Sales Proportion of Safety Lancets by Product in 2024
 Table 145. Sarstedt Sales Proportion of Safety Lancets by Application in 2024
 Table 146. Sarstedt Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 147. Sarstedt Recent Developments
 Table 148. UltiMed Company Information
 Table 149. UltiMed Description and Business Overview
 Table 150. UltiMed Safety Lancets Product
 Table 151. UltiMed Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 152. UltiMed Sales Proportion of Safety Lancets by Product in 2024
 Table 153. UltiMed Sales Proportion of Safety Lancets by Application in 2024
 Table 154. UltiMed Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 155. UltiMed Recent Developments
 Table 156. Tianjin Huahong Company Information
 Table 157. Tianjin Huahong Description and Business Overview
 Table 158. Tianjin Huahong Safety Lancets Product
 Table 159. Tianjin Huahong Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 160. Tianjin Huahong Sales Proportion of Safety Lancets by Product in 2024
 Table 161. Tianjin Huahong Sales Proportion of Safety Lancets by Application in 2024
 Table 162. Tianjin Huahong Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 163. Tianjin Huahong Recent Developments
 Table 164. Guangzhou iCare Medical Company Information
 Table 165. Guangzhou iCare Medical Description and Business Overview
 Table 166. Guangzhou iCare Medical Safety Lancets Product
 Table 167. Guangzhou iCare Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 168. Guangzhou iCare Medical Sales Proportion of Safety Lancets by Product in 2024
 Table 169. Guangzhou iCare Medical Sales Proportion of Safety Lancets by Application in 2024
 Table 170. Guangzhou iCare Medical Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 171. Guangzhou iCare Medical Recent Developments
 Table 172. Shandong Lianfa Company Information
 Table 173. Shandong Lianfa Description and Business Overview
 Table 174. Shandong Lianfa Safety Lancets Product
 Table 175. Shandong Lianfa Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 176. Shandong Lianfa Sales Proportion of Safety Lancets by Product in 2024
 Table 177. Shandong Lianfa Sales Proportion of Safety Lancets by Application in 2024
 Table 178. Shandong Lianfa Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 179. Shandong Lianfa Recent Developments
 Table 180. SteriLance Medical Company Information
 Table 181. SteriLance Medical Description and Business Overview
 Table 182. SteriLance Medical Safety Lancets Product
 Table 183. SteriLance Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
 Table 184. SteriLance Medical Sales Proportion of Safety Lancets by Product in 2024
 Table 185. SteriLance Medical Sales Proportion of Safety Lancets by Application in 2024
 Table 186. SteriLance Medical Sales Proportion of Safety Lancets by Geographic Area in 2024
 Table 187. SteriLance Medical Recent Developments
 Table 188. North America Safety Lancets Sales by Country (2020-2025) & (M Units)
 Table 189. North America Safety Lancets Sales by Country (2026-2031) & (M Units)
 Table 190. North America Safety Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 191. North America Safety Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 192. North America Safety Lancets Sales by Type (2020-2025) & (M Units)
 Table 193. North America Safety Lancets Sales by Application (2020-2025) & (M Units)
 Table 194. Asia-Pacific Safety Lancets Sales by Region (2020-2025) & (M Units)
 Table 195. Asia-Pacific Safety Lancets Sales by Region (2026-2031) & (M Units)
 Table 196. Asia-Pacific Safety Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 197. Asia-Pacific Safety Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 198. Asia-Pacific Safety Lancets Sales by Type (2020-2025) & (M Units)
 Table 199. Asia-Pacific Safety Lancets Sales by Application (2020-2025) & (M Units)
 Table 200. Europe Safety Lancets Sales by Country (2020-2025) & (M Units)
 Table 201. Europe Safety Lancets Sales by Country (2026-2031) & (M Units)
 Table 202. Europe Safety Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 203. Europe Safety Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 204. Europe Safety Lancets Sales by Type (2020-2025) & (M Units)
 Table 205. Europe Safety Lancets Sales by Application (2020-2025) & (M Units)
 Table 206. Latin America Safety Lancets Sales by Country (2020-2025) & (M Units)
 Table 207. Latin America Safety Lancets Sales by Country (2026-2031) & (M Units)
 Table 208. Latin America Safety Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 209. Latin America Safety Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 210. Latin America Safety Lancets Sales by Type (2020-2025) & (M Units)
 Table 211. Latin America Safety Lancets Sales by Application (2020-2025) & (M Units)
 Table 212. Middle East and Africa Safety Lancets Sales by Country (2020-2025) & (M Units)
 Table 213. Middle East and Africa Safety Lancets Sales by Country (2026-2031) & (M Units)
 Table 214. Middle East and Africa Safety Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 215. Middle East and Africa Safety Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 216. Middle East and Africa Safety Lancets Sales by Type (2020-2025) & (M Units)
 Table 217. Middle East and Africa Safety Lancets Sales by Application (2020-2025) & (M Units)
 Table 218. Safety Lancets Key Raw Materials, Industry Status and Trend
 Table 219. Safety Lancets Key Raw Materials and Upstream Suppliers
 Table 220. Safety Lancets Clients Status and Trend
 Table 221. Safety Lancets Typical Clients
 Table 222. Safety Lancets Distributors
 Table 223. Safety Lancets Market Trends
 Table 224. Safety Lancets Market Drivers
 Table 225. Safety Lancets Market Challenges
 Table 226. Safety Lancets Market Restraints
 Table 227. Research Programs/Design for This Report
 Table 228. Key Data Information from Secondary Sources
 Table 229. Key Data Information from Primary Sources
 Table 230. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Safety Lancets Product Picture
 Figure 2. Global Safety Lancets Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Safety Lancets Sales Market Share by Type in 2024 & 2031
 Figure 4. Safety Lancets with Needle Product Picture
 Figure 5. Safety Lancets with Blade Product Picture
 Figure 6. Global Safety Lancets Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Safety Lancets Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital & Clinics
 Figure 9. Home
 Figure 10. Other
 Figure 11. Safety Lancets Report Years Considered
 Figure 12. Global Safety Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Safety Lancets Market Size 2020-2031 (US$ Million)
 Figure 14. Global Safety Lancets Sales 2020-2031 (M Units)
 Figure 15. Global Safety Lancets Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Safety Lancets Revenue Market Share by Region (2020-2031)
 Figure 17. Global Safety Lancets Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Safety Lancets Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Safety Lancets Average Selling Price (ASP) by Type (2020-2025) & (US$/K Units)
 Figure 20. Global Safety Lancets Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Safety Lancets Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Safety Lancets Average Selling Price (ASP) by Application (2020-2025) & (US$/K Units)
 Figure 23. Safety Lancets with Needle of Safety Lancets Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Safety Lancets with Blade of Safety Lancets Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Safety Lancets Sales Share by Manufacturer in 2024
 Figure 26. Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Safety Lancets with Needle Market Sales Proportion by Manufacturer in 2024
 Figure 28. Safety Lancets with Blade Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Safety Lancets Revenue 2020-2031 (US$ Million)
 Figure 30. North America Safety Lancets Sales Market Share by Type (2020-2025)
 Figure 31. North America Safety Lancets Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Safety Lancets Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Safety Lancets Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Safety Lancets Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Safety Lancets Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Safety Lancets Sales Market Share by Application (2020-2025)
 Figure 37. Europe Safety Lancets Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Safety Lancets Sales Market Share by Country (2020-2031)
 Figure 39. Europe Safety Lancets Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Safety Lancets Sales Market Share by Type (2020-2025)
 Figure 41. Europe Safety Lancets Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Safety Lancets Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Safety Lancets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Safety Lancets Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Safety Lancets Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Safety Lancets Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Safety Lancets Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Safety Lancets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Safety Lancets Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Safety Lancets Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Safety Lancets Sales Market Share by Application (2020-2025)
 Figure 52. Safety Lancets Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Safety Lancets Raw Materials by Region in 2024
 Figure 54. Safety Lancets Distribution Channels
 Figure 55. Global Safety Lancets Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Safety Lancets Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Medical Safety Lancet Market Research Report 2025
Global Safety Blood Lancet Market Research Report 2025
Global Safety Capillary Blood Collection Lancet Market Research Report 2025
Global Safety Capillary Blood Collection Needle Market Research Report 2025
Global Safety Lancets for Diabetes Market Research Report 2025
Disposable Safety Lancets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Micro sampling Safety Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Capillary Blood Collection Lancet Market Research Report 2025
Global Blood Micro sampling Medical Devices Market Research Report 2025
Global Safety Skin Puncture Lancet Market Research Report 2025
Global Pressure Activated Safety Lancets Market Research Report 2024
Global Medical Blood Lancet Market Research Report 2025
Global Single use Safety Lancet Market Research Report 2025
Global Sterile Lancets Market Research Report 2024
Global Safety Venous Needle Market Research Report 2024
Global Skin Puncture Lancet Market Research Report 2025
Global Sterile Single Use Safety Lancet Market Research Report 2024
Global Lancets Market Research Report 2024
Global Safety Venous Blood Collection Needle Market Research Report 2024
Global Safety Blood Collection Sets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions